Pharmolix.com

China Founded: 2023 • Age: 3 yrs
Biotechnology company that develops and commercializes AI-powered foundation models for the biomedical industry

About Pharmolix.com

Pharmolix.com is a Healthcare company based in China founded in 2023. It operates as a biotechnology company that develops and commercializes AI-powered foundation models for the biomedical industry. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group and 2 more; 6 of its 7 listed competitors have raised funding.

Company details

PharMolix is a biotechnology company that leverages artificial intelligence (AI) to revolutionize the biomedical industry. They develop multimodal AI foundation models for various applications, including language modeling, molecular representation, and mutation explanation.

Key Metrics

Funding Insights of Pharmolix.com

  • Total Rounds 1
  • Investors Count 4

All 1 funding rounds of Pharmolix.com with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2024–Series A––
Valuation history

4 investors in total: 4 institutional.

Investors in Pharmolix.com

Pharmolix.com has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Huashan Capital, Dalton Venture and xfyun.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
VC firm investing in FinTech startups
–huashancapital.com-
Medical industry focused VC firm
–daltonventure.cnShanghai, China
Provides comprehensive AI-focused development services to enhance technological solutions.
2014xfyun.cnHefei, China
Investment services are offered by Tsingzhi Capital to clients.
–tsingzhicap.com-
Premium access

Investor details for Pharmolix.com

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Pharmolix.com

2 dated milestones of Pharmolix.com across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded Pharmolix.com is founded.
  2. Funding First funding round.

Competitors of Pharmolix.com

Pharmolix.com has 7 listed competitors in our database, 6 of them funded. They include Fauna Bio, BeaconCure, Predxbio, Lila Sciences and Humaneva Group, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
faunabio.com2018Berkeley, United States$13.1M19
Animal genomics is applied to healthcare advancements by Fauna Bio.
beaconcure.com2016Tel Aviv, Israel$40.92M–
Data analytics and validation software for regulatory submission in the healthcare sector
predxbio.com2017Pittsburgh, United States$1.4M–
AI-based drug discovery and clinical services are provided for biopharma.
lila.ai2023–$550M–
AI-powered platforms for autonomous scientific research are developed.
humaneva.com2014Raleigh, United States$50M–
Provider of clinical research data services for oncology & other therapeutic areas
privatehealth.com2007Los Angeles, United States––
Provides personalized healthcare guidance for complex diseases and partnerships.
rgnmed.com2014Greenwich, United States$290,000–
Healthcare data analytics company that enables clinical and financial value creation for clinicians
Premium access

Detailed competitors of Pharmolix.com

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

10 companies that operate in the same segment as Pharmolix.com (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M1,820
Drug discovery and development services are provided to biopharma sector.
1993Hamburg, Hamburg, GermanyUSD 25 MUSD 926.33 M4,830
Drug discovery and development services for small molecules are provided.
2003Beijing, ChinaUSD 320 M–476
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 255.15 MUSD 374.1 M4,490
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M12,470
Pharmaceutical products for treating multiple diseases are provided.
1849New York, New York, United StatesUSD 8 MUSD 266.99 M1,770
Provider of laboratory tests for physicians
1969Burlington, Vermont, United States–USD 13.95 B70,000
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M4,260
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Pharmolix.com

Pharmolix.com was founded in 2023 and raised its 1st funding round 1 year after it was founded.

Pharmolix.com is headquartered in China.

PharMolix is a biotechnology company that leverages artificial intelligence (AI) to revolutionize the biomedical industry. They develop multimodal AI foundation models for various applications, including language modeling, molecular representation, and mutation explanation.

Pharmolix.com's top competitors include Fauna Bio, Predxbio and Lila Sciences.

Pharmolix.com has 4 investors. Key investors include Huashan Capital, Dalton Venture, xfyun, and Tsingzhi Capital.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available